Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and effects on quality of life. Research, Society and Development, [S. l.], v. 14, n. 5, p. e4914548812, 2025. DOI: 10.33448/rsd-v14i5.48812. Disponível em: https://rsdjournal.org/rsd/article/view/48812. Acesso em: 5 dec. 2025.